Shareholder Rights Advocates at Levi & Korsinsky Investigate Zymeworks Inc. (ZYME) Regarding Possible Securities Fraud Violations
Zymeworks Inc. (NYSE: ZYME) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
ATTENTION Zymeworks Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
Zymeworks Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - ZYME